INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 45 filers reported holding INSMED INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $7,294,000 | +2208.2% | 7,500,000 | +1910.7% | 0.41% | +1552.0% |
Q1 2020 | $316,000 | -90.4% | 373,000 | -90.5% | 0.02% | -88.2% |
Q3 2019 | $3,279,000 | -32.4% | 3,920,000 | -21.6% | 0.21% | -24.4% |
Q2 2019 | $4,853,000 | +229.7% | 5,000,000 | +241.8% | 0.28% | +217.0% |
Q1 2019 | $1,472,000 | +4.2% | 1,463,000 | -26.8% | 0.09% | -7.4% |
Q4 2018 | $1,412,000 | -55.5% | 2,000,000 | -43.9% | 0.10% | -39.9% |
Q1 2018 | $3,170,000 | – | 3,565,000 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |